XOMA Announces Positive Results From U.S. Phase 1 Trial of XOMA 052 in Type 2 Diabetes Jul 14, 2009 4:27pm EDT
XOMA Announces Conference Call and Webcast On July 14 to Review Top Line Multi-dose and Other Results of Its Phase 1 Clinical Trial of XOMA 052 in Type 2 Diabetes Jul 07, 2009 7:00am EDT
XOMA Presents Data At ADA Demonstrating Improvement in Diabetes and Inflammatory Measures in Animal Model With XOMA 052 Jun 08, 2009 4:25pm EDT
XOMA 052 Clinical Results Support Novel Anti-Inflammatory Approach to Type 2 Diabetes Treatment Jun 06, 2009 5:20pm EDT
XOMA Announces Clinical and Preclinical Presentations At American Diabetes Association 69th Scientific Sessions May 26, 2009 11:55am EDT
XOMA Royalties On CIMZIA(r) Expected to Increase Due to FDA Approval for Moderate to Severe Rheumatoid Arthritis in Adults May 14, 2009 3:25pm EDT
